Thousand Oaks, CA-headquartered pharmaceutical company Amgen, announced plans to invest $200 million in 2025 to establish its new technology and innovation center in Hyderabad, southern India. CEO Robert Bradway made this announcement during the site's inauguration on Monday, Feb 24, adding that significant additional investments are planned for future years....
Nestlé, Dr. Reddy’s Form JV to bring Nature’s Bounty to India
In a significant market development, Nestlé India and Dr. Reddy's Laboratories established a joint venture focused on bringing innovative nutraceutical brands to consumers in India and other agreed territories. The strategic partnership aims to combine Nestlé Health Science's global range of nutritional health solutions with Dr. Reddy's strong commercial capabilities...
Amgen India to Accelerate Innovation, Digital Capabilities
THOUSAND OAKS, CA-based Amgen announced plans to open a new technology and innovation site in Hyderabad, India. The site, known as Amgen India, will accelerate digital capabilities across the global organization to further advance Amgen's pipeline of medicines. Amgen India will be located in HITEC City, a suburb of Hyderabad,...
Google leverages India’s Salcit Technologies to Detect Disease
Google has introduced an AI model called HeAR (Health Acoustic Representations), designed to detect early signs of disease using acoustic data. This innovative technology is part of Google’s broader efforts to leverage generative AI for healthcare applications, moving beyond its typical use in creative and productivity tools. Accessibility and Cost-Effectiveness:...
Dr. Reddy’s, Bayer, Partner to Market Heart Drug in India
Hyderabad, India-based Dr. Reddy's Laboratories Ltd. and Bayer have entered into a partnership to market and distribute a second brand of the drug Vericiguat in India. Under the agreement, Bayer has granted non-exclusive rights to Dr. Reddy's to sell Vericiguat under the brand name Gantra. Vericiguat is a soluble guanylate...
German Firm Miltenyi Biotec to Launch Operations in India
German firm Miltenyi Biotec, will launch operations in India with its first office and invest in setting up the Miltenyi Innovation and Technology Center as a Cell and Gene Therapy (CGT) Center of Excellence in Hyderabad. The company aims to enable local development and manufacturing in India to drive affordable...